Literature DB >> 15113878

The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.

Gregory K Hong1, Henri-Jacques Delecluse, Henri Gruffat, Thomas E Morrison, Wen-Hai Feng, Alain Sergeant, Shannon C Kenney.   

Abstract

The switch from the latent to the lytic form of Epstein-Barr virus (EBV) infection is mediated by expression of the viral immediate-early (IE) proteins, BZLF1 (Z) and BRLF1 (R). An EBV early protein, BRRF1 (Na), is encoded by the opposite strand of the BRLF1 intron, but the function of this nuclear protein in the viral life cycle is unknown. Here we demonstrate that Na enhances the R-mediated induction of lytic EBV infection in 293 cells latently infected with a recombinant EBV (R-KO) defective for the expression of both R and Na. Na also enhances R-induced lytic infections in a gastric carcinoma line (AGS) carrying the R-KO virus, although it has no effect in a Burkitt lymphoma line (BL-30) stably infected with the same mutant virus. We show that Na is a transcription factor that increases the ability of R to activate Z expression from the R-KO viral genome in 293 cells and that Na by itself activates the Z promoter (Zp) in EBV-negative cells. Na activation of Zp requires a CRE motif (ZII), and a consensus CRE motif is sufficient to transfer Na responsiveness to the heterologous E1b promoter. Furthermore, we show that Na enhances the transactivator function of a Gal4-c-Jun fusion protein but does not increase the transactivator function of other transcription factors (including ATF-1, ATF-2, and CREB) known to bind CRE motifs. Na expression in cells results in increased levels of a hyperphosphorylated form of c-Jun, suggesting a mechanism by which Na activates c-Jun. Our results indicate that Na is a transcription factor that activates the EBV Zp IE promoter through its effects on c-Jun and suggest that Na cooperates with BRLF1 to induce the lytic form of EBV infection in certain cell types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113878      PMCID: PMC400377          DOI: 10.1128/jvi.78.10.4983-4992.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  Epstein-Barr virus infection and replication in a human epithelial cell system.

Authors:  Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

2.  ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.

Authors:  N Taylor; E Flemington; J L Kolman; R P Baumann; S H Speck; G Miller
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Pathways of activation of the Epstein-Barr virus productive cycle.

Authors:  A J Sinclair; M Brimmell; F Shanahan; P J Farrell
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter.

Authors:  H Gruffat; N Duran; M Buisson; F Wild; R Buckland; A Sergeant
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

5.  The enhancer factor R of Epstein-Barr virus (EBV) is a sequence-specific DNA binding protein.

Authors:  H Gruffat; E Manet; A Rigolet; A Sergeant
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

6.  Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter.

Authors:  S Liu; A M Borras; P Liu; G Suske; S H Speck
Journal:  Virology       Date:  1997-02-03       Impact factor: 3.616

7.  Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus.

Authors:  L Karimi; D H Crawford; S Speck; L J Nicholson
Journal:  J Gen Virol       Date:  1995-04       Impact factor: 3.891

8.  The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.

Authors:  Y N Chang; D L Dong; G S Hayward; S D Hayward
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

9.  Phosphorylation of c-jun mediated by MAP kinases.

Authors:  B J Pulverer; J M Kyriakis; J Avruch; E Nikolakaki; J R Woodgett
Journal:  Nature       Date:  1991-10-17       Impact factor: 49.962

10.  Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia.

Authors:  L S Young; R Lau; M Rowe; G Niedobitek; G Packham; F Shanahan; D T Rowe; D Greenspan; J S Greenspan; A B Rickinson; P J Farrell
Journal:  J Virol       Date:  1991-06       Impact factor: 6.549

View more
  37 in total

1.  Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.

Authors:  Andreas M F Heilmann; Michael A Calderwood; Eric Johannsen
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

2.  The ORF49 protein of murine gammaherpesvirus 68 cooperates with RTA in regulating virus replication.

Authors:  Sangmi Lee; Hye-Jeong Cho; Jung-Jin Park; Yong-Sun Kim; Seungmin Hwang; Ren Sun; Moon Jung Song
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

3.  Negative autoregulation of Epstein-Barr virus (EBV) replicative gene expression by EBV SM protein.

Authors:  Dinesh Verma; Chen Ling; Eric Johannsen; Tirumuru Nagaraja; Sankar Swaminathan
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

4.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.

Authors:  Stacy R Hagemeier; Sarah J Dickerson; Qiao Meng; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  Viral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.

Authors:  Coral K Wille; Dhananjay M Nawandar; Amanda R Panfil; Michelle M Ko; Stacy R Hagemeier; Shannon C Kenney
Journal:  J Virol       Date:  2012-11-07       Impact factor: 5.103

Review 7.  Regulation of the latent-lytic switch in Epstein-Barr virus.

Authors:  Shannon C Kenney; Janet E Mertz
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

8.  The Rad6/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity.

Authors:  Ravindra Kumar; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

9.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters.

Authors:  Sarah J Dickerson; Yongna Xing; Amanda R Robinson; William T Seaman; Henri Gruffat; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2009-03-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.